Document is current

Article History

First Online: 27 January 2021

Compliance with ethical standards

:

: JJH reports having received consulting fees from GSK, Alexion, Travere, Zyversa, Dimerix, Aurinia and Goldfinch Bio. He also reports salary support through grant funding as site principle investigator for studies from the National Institutes of Health, Gilead, GSK, Regeneron, Boehringer Ingelheim, Travere, Achillion, Calliditas, Omeros, and BMS. He receives royalties from UpToDate.com for topics written on calcium-phosphorous balance and monoclonal gammopathies of renal significance. He also is a co-inventor and has received royalties related to a pending patent involving the use of synthetic immunoreceptor engineered T cells for the treatment of membranous nephropathy. LHB has received research support from Sanofi Genzyme, Boston University Medical Center, is co-inventor US patent “Diagnostics for Membranous Nephropathy” with royalty income through Boston University, receives royalties from UpToDate.com for topic cards related to membranous nephropathy, has received served on advisory boards and received honoraria from Genentech, Visterra, Ionis, Alexion, and is a site PI on a clinical trial sponsored by Pfizer for novel therapeutics in FSGS. JZ has no conflicts of interests to declare.

: This article does not contain any studies with human or animal subjects performed by any of the authors.

: For this type of study informed consent is not required.

Free to read: This content has been made available to all.